Therapeutic Effects of Myriocin in Experimental Alcohol-Related Neurobehavioral Dysfunction and Frontal Lobe White Matter Biochemical Pathology

Background & Objective: Chronic excessive alcohol consumption causes white matter degeneration with myelin loss and impaired neuronal conductivity. Subsequent rarefaction of myelin accounts for the sustained deficits in cognition, learning, and memory. Correspondingly, chronic heavy or repeated binge alcohol exposures in humans and experimental models alter myelin lipid composition leading to build-up of ceramides which can be neurotoxic and broadly inhibitory to brain functions. Methods: This study examined the effects of chronic + binge alcohol exposures (8 weeks) and intervention with myriocin, a ceramide inhibitor, on neurobehavioral functions (Open Field, Novel Object Recognition, and Morris Water Maze tests) and frontal lobe white matter myelin lipid biochemical pathology in an adult Long-Evans rat model. Results: The ethanol-exposed group had significant deficits in executive functions with increased indices of anxiety and impairments in spatial learning acquisition. Myriocin partially remediated these effects of ethanol while not impacting behavior in the control group. Ethanol-fed rats had significantly smaller brains with broadly reduced expression of sulfatides and reduced expression of two of the three sphingomyelins detected in frontal white matter. Myriocin partially resolved these effects corresponding with improvements in neurobehavioral function. Conclusion: Therapeutic strategies that support cerebral white matter myelin expression of sulfatide and sphingomyelin may help remediate cognitive-behavioral dysfunction following chronic heavy alcohol consumption in humans.

• Publication year

  2022

• Venue

  Journal of Behavioral and Brain Science

• Publication date

  2022-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4236/jbbs.2022.122003PMID 36815096PMCID 9942847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats

  2020cited by this paper
• Fingolimod targets cerebral endothelial activation to block leukocyte recruitment in the central nervous system

  2018cited by this paper
• p21-activated kinase 1 activity is required for histone H3 Ser10 phosphorylation and chromatin condensation in mouse oocyte meiosis.

  2017cited by this paper
• Progressive white matter atrophy with altered lipid profiles is partially reversed by short-term abstinence in an experimental model of alcohol-related neurodegeneration.

  2017cited by this paper
• Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.

  2017cited by this paper
• Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease

  2017cited by this paper
• Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.

  2017cited by this paper
• Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.

  2015cited by this paper
• Differential Sphingolipid and Phospholipid Profiles in Alcohol and Nicotine-Derived Nitrosamine Ketone-Associated White Matter Degeneration.

  2015cited by this paper
• Differential Lipid Profiles in Experimental Steatohepatitis: Role for Imaging Mass Spectrometry as a Diagnostic Aid

  2015cited by this paper
• Review of Matrix-Assisted Laser Desorption Ionization-Imaging Mass Spectrometry for Lipid Biochemical Histopathology

  2015cited by this paper
• Lipid rafts as major platforms for signaling regulation in cancer.

  2015cited by this paper
• White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke.

  2015cited by this paper
• Novel Object Recognition for Studying Memory in Mice

  2014cited by this paper
• Ceramide metabolism analysis in a model of binge drinking reveals both neuroprotective and toxic effects of ethanol

  2014cited by this paper
• Therapeutic reversal of chronic alcohol‐related steatohepatitis with the ceramide inhibitor myriocin

  2014cited by this paper
• A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.

  2014cited by this paper
• Human alcohol-related neuropathology

  2013cited by this paper
• Sphingomyelin and its role in cellular signaling.

  2013cited by this paper
• Involvement of Sphingolipids in Ethanol Neurotoxicity in the Developing Brain

  2013cited by this paper
• Mouse model of chronic and binge ethanol feeding (the NIAAA model)

  2013cited by this paper
• Lipid imaging by mass spectrometry - a review.

  2013cited by this paper
• Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: A critical role for E‐selectin

  2013cited by this paper
• White matter volume in alcohol use disorders: a meta‐analysis

  2013cited by this paper
• Ceramide function in the brain: when a slight tilt is enough

  2012cited by this paper
• Enhanced sensitivity for high spatial resolution lipid analysis by negative ion mode matrix assisted laser desorption ionization imaging mass spectrometry.

  2012cited by this paper
• Binary matrix for MALDI imaging mass spectrometry of phospholipids in both ion modes.

  2011cited by this paper
• A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

  2011cited by this paper
• MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

  2011cited by this paper
• Analysis of native biological surfaces using a 100 kV massive gold cluster source.

  2011cited by this paper
• Developmental profiling by mass spectrometry of phosphocholine containing phospholipids in the rat nervous system reveals temporo‐spatial gradients

  2010cited by this paper
• White matter pathology isolates the hippocampal formation in Alzheimer's disease.

  2010cited by this paper
• Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study.

  2010cited by this paper
• Gene expression profiling--Clusters of possibilities.

  2010cited by this paper
• Lipid rafts: keys to neurodegeneration.

  2010cited by this paper
• Mechanisms of Ceramide-Mediated Neurodegeneration

  2009cited by this paper
• A detailed analysis of open-field habituation and behavioral and neurochemical antidepressant-like effects in postweaning enriched rats.

  2009cited by this paper
• Alcohol-Related Neurodegeneration and Recovery: Mechanisms from Animal Models

  2008cited by this paper
• Alcohol-Related Neurodegeneration and Recovery

  2008cited by this paper
• Association of alcohol consumption with brain volume in the Framingham study.

  2008cited by this paper
• Sulfatide Storage in Neurons Causes Hyperexcitability and Axonal Degeneration in a Mouse Model of Metachromatic Leukodystrophy

  2007cited by this paper
• Molecular profiling of native and matrix-coated tissue slices from rat brain by infrared and ultraviolet laser desorption/ionization orthogonal time-of-flight mass spectrometry.

  2007cited by this paper
• In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS

  2007cited by this paper
• Brain Morphometry and Cognitive Performance in Detoxified Alcohol-Dependents with Preserved Psychosocial Functioning

  2007cited by this paper
• Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease

  2006cited by this paper
• Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study.

  2006cited by this paper
• Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?

  2005cited by this paper
• Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons.

  2005cited by this paper
• Lipid Microdomains and Insulin Resistance: Is There a Connection?

  2005cited by this paper
• Behavioral deficits associated with fetal alcohol exposure are reversed by prenatal thyroid hormone treatment: a role for maternal thyroid hormone deficiency in FAE

  2005cited by this paper
• Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice.

  2004cited by this paper
• Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre.

  2003cited by this paper
• Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

  2002cited by this paper
• Sphingolipids in mammalian cell signalling

  2001cited by this paper
• Behavioral tests of hippocampal function: simple paradigms complex problems.

  2001cited by this paper
• Characterization of phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate by electrospray ionization tandem mass spectrometry: A mechanistic study

  2000cited by this paper
• Pattern of motor and cognitive deficits in detoxified alcoholic men.

  2000cited by this paper
• Brain shrinkage in alcoholics: a decade on and what have we learned?

  1999cited by this paper
• Chemistry and functional distribution of sulfoglycolipids.

  1997cited by this paper
• Impairments of Brain and Behavior

  1997cited by this paper
• Lesions of supracallosal or infracallosal hippocampal pathways in the rat: behavioral, neurochemical, and histochemical effects.

  1994cited by this paper
• Disproportionate atrophy of cerebral white matter in chronic alcoholics.

  1988cited by this paper
• Effects of Ethanol on Drug and Metabolite Pharmacokinetics

  1985cited by this paper
• CSF, plasma, and urine: what do concomitant measurements of norepinephrine and its metabolites mean?

  1985cited by this paper
• Drug Interactions With Alcohol

  1979cited by this paper

• Dual Stages of Alcohol-Related Cerebral White Matter Degeneration Reviewed: Early-Stage Stress/Neuroinflammation Versus Late-Stage Impaired Insulin/IGF Signaling Through Akt-mTOR–Review

  2025influential citation
• Progressive Alcohol-Related Brain Atrophy and White Matter Pathology Are Linked to Long-Term Inhibitory Effects on mTOR Signaling

  2025influential citation
• Experimental verification of Myriocin molecular bioactivity in revoking rheumatoid arthritis: New emphasis on S100A1 repression and PPAR-γ activation via non-canonical pathways in the flare-up of cytokines.

  2025cites this paper
• Alpha-Lipoic Acid in Early-Stage Alcohol-Related Brain Damage in Rats: A Comparative Pilot Study

  2025cites this paper
• Methyl-beta-cyclodextrin and myriocin alleviate blood–brain barrier impairment in septic rats

  2025cites this paper
• Differential effects of moderate chronic ethanol consumption on neurobehavior, white matter glial protein expression, and mTOR pathway signaling with adolescent brain maturation

  2024cites this paper
• Dysregulated mTOR networks in experimental sporadic Alzheimer’s disease

  2024cites this paper
• Tissue Microarray Lipidomic Imaging Mass Spectrometry Method: Application to the Study of Alcohol-Related White Matter Neurodegeneration

  2023cites this paper
• Differential Early Mechanistic Frontal Lobe Responses to Choline Chloride and Soy Isoflavones in an Experimental Model of Fetal Alcohol Spectrum Disorder

  2023cites this paper
• Dietary Soy Prevents Alcohol-Mediated Neurocognitive Dysfunction and Associated Impairments in Brain Insulin Pathway Signaling in an Adolescent Rat Model

  2022cites this paper